Showing results (1321-1330 of 1,685) with videos related to

Sort By:
Pageof 169
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeDallas R English, Joanne P Young, Julie A Simpson, et al.
Annals of Neurology|April 14, 2015
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiologyJanelle Drouin-Ouellet, Stephen J Sawiak, Giulia Cisbani, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 31, 2018
Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's studyNaveed Malek, Rimona S Weil, Catherine Bresner, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 28, 2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's DiseaseSimon Rowe, Amy Evans, Saeed Kayhanian, et al.
Journal of Parkinson'S Disease|February 17, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshopRoger A Barker, Mart Saarma, Clive N Svendsen, et al.
The Review of Scientific Instruments|July 10, 2021
Understanding the effects of neutron scattering for neutron-yield-isotropy measurements at the NIFK D Hahn, R M Bionta, H Khater, et al.
Scientific Reports|July 15, 2017
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's diseaseAlba Di Pardo, Enrico Amico, Abdul Basit, et al.
Pageof 169